Pay in 4 interest-free payments of $37.19 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
25-12 of around 14 000 h•ng/mL contributed to an excellent oral bioavailability of PQR-309 (>50%)
Interactions of sulfaproxyline and of sulfamerazine with blood proteins]
the in vitro proliferation of MH3924A cells is increased (P<0
is an activator of the GTP-binding protein Rab7 (EC50 = 77
CAS Number: 208255-80-5
Pomalidomide HCl 25-12 of around 14 000Pomalidomide, also known as CC4047, is an orally bioavailable derivative of thalidomide with potential immunomodulating, antiangiogenic and antineoplastic activities. Although its exact mechanism of action has yet to be fully elucidated, pomalidomide appears to inhibit TNF alpha production, enhance the activity of T cells and natural killer (NK) cells and enhance antibody dependent cellular cytotoxicity (ADCC). Pomalidomide was approved on February 8,
US$ 193.50
US$ 115.00
US$ 549.00
US$ 50.00
US$ 12.00
US$ 137.50
US$ 2985.50